American International Group’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-22,894
Closed -$120K 2489
2024
Q1
$120K Sell
22,894
-197
-0.9% -$943 ﹤0.01% 2416
2023
Q4
$74.8K Buy
23,091
+248
+1% +$535 ﹤0.01% 2700
2023
Q3
$58.3K Buy
22,843
+812
+4% +$3.4K ﹤0.01% 2777
2023
Q2
$129K Buy
22,031
+1,134
+5% +$6.59K ﹤0.01% 2426
2023
Q1
$59.6K Buy
20,897
+7,678
+58% +$21.6K ﹤0.01% 2664
2022
Q4
$26.6K Sell
13,219
-48
-0.4% -$117 ﹤0.01% 2887
2022
Q3
$38K Buy
13,267
+187
+1% +$873 ﹤0.01% 2885
2022
Q2
$74K Sell
13,080
-1,115
-8% -$9.02K ﹤0.01% 2738
2022
Q1
$167K Buy
14,195
+6,794
+92% +$82.3K ﹤0.01% 2354
2021
Q4
$140K Sell
7,401
-222
-3% -$4.84K ﹤0.01% 2563
2021
Q3
$157K Buy
+7,623
New +$164K ﹤0.01% 2577

Other funds holding TNYA

American International Group's TNYA Position: Q2 2024 in Review

American International Group sold out of Tenaya Therapeutics (TNYA) in Q2 2024, closing a stake of 22,894 shares — an estimated $120K sold.

American International Group first reported a position in TNYA in Q3 2021 and held it in 11 quarters. The position peaked at $167K in Q1 2022. 96 funds tracked by Wall St. Rank hold TNYA as of Q2 2024.

  • American International Group reported no remaining Tenaya Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 22,894 Tenaya Therapeutics shares in Q2 2024, an estimated $120K.
  • American International Group first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 11 quarters.
  • American International Group's Tenaya Therapeutics position peaked at $167K in Q1 2022.
  • 96 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.